| Dr Christian Michael Chiavetta, DO | |
|
18460 Roscoe Blvd Fl 3, Northridge, CA 91325-4107 | |
| (818) 885-5480 | |
| (818) 993-1917 |
| Full Name | Dr Christian Michael Chiavetta |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 18460 Roscoe Blvd Fl 3, Northridge, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356701890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 20A14593 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northridge Hospital Medical Center | Northridge, CA | Hospital |
| West Hills Hospital & Medical Center | West hills, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Medicine Of California Inc | 4688952906 | 50 |
| Dignity Health Medical Foundation | 7810800661 | 1209 |
| Renal Consultants Medical Group | 9335126010 | 11 |
News Archive
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
For many people, mistletoe conjures up images of Christmas holidays, but in parts of Europe, mistletoe extract is widely used as a therapy for cancer patients. However, a new review of studies finds only weak evidence that the treatment provides any benefit.
New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
› Verified 8 days ago
| Entity Name | Dignity Health Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709 |
News Archive
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
For many people, mistletoe conjures up images of Christmas holidays, but in parts of Europe, mistletoe extract is widely used as a therapy for cancer patients. However, a new review of studies finds only weak evidence that the treatment provides any benefit.
New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
› Verified 8 days ago
| Entity Name | Renal Consultants Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912042342 PECOS PAC ID: 9335126010 Enrollment ID: O20040630000997 |
News Archive
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
For many people, mistletoe conjures up images of Christmas holidays, but in parts of Europe, mistletoe extract is widely used as a therapy for cancer patients. However, a new review of studies finds only weak evidence that the treatment provides any benefit.
New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
› Verified 8 days ago
| Entity Name | Hospital Medicine Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770037236 PECOS PAC ID: 4688952906 Enrollment ID: O20161020001556 |
News Archive
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
For many people, mistletoe conjures up images of Christmas holidays, but in parts of Europe, mistletoe extract is widely used as a therapy for cancer patients. However, a new review of studies finds only weak evidence that the treatment provides any benefit.
New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christian Michael Chiavetta, DO 3400 Data Dr, Rancho Cordova, CA 95670-7956 Ph: () - | Dr Christian Michael Chiavetta, DO 18460 Roscoe Blvd Fl 3, Northridge, CA 91325-4107 Ph: (818) 885-5480 |
News Archive
Scientists are hopeful that a new drug - called EIDD-2801 - could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
For many people, mistletoe conjures up images of Christmas holidays, but in parts of Europe, mistletoe extract is widely used as a therapy for cancer patients. However, a new review of studies finds only weak evidence that the treatment provides any benefit.
New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
› Verified 8 days ago
Dr. Prathima Smruthi Charugundla, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 548-081-8885 Fax: 818-993-1917 | |
Amber Kristy Williams, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Shadi Sharif, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Dr. Sandeep Chadha, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Michael E Damavandi, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Marta Beth Almli, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Dr. Lesley Prince, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 |